We are live on ! Find out more
CLYM

Climb Bio
CLYM

76 hedge funds and large institutions have $63.4M invested in Climb Bio in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 23

5% less funds holding

Funds holding: 80 → 76 (-4)

5.9% less ownership

Funds ownership: 82.87% → 76.97% (-5.9%)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

37% less capital invested

Capital invested by funds: $100M → $63.4M (-$36.9M)

Holders
76
Holders Change
-4
Holders Change %
-5%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
23
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$2.96M
2
CF
Cantor Fitzgerald
New York
+$2.19M
3
AAA
Affinity Asset Advisors
New York
+$1.62M
4
TCM
Tang Capital Management
California
+$1.62M
5
PLC
Peapod Lane Capital
New York
+$898K

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.72M
2
SB
Samsara BioCapital
California
-$4.7M
3
BCM
Boxer Capital Management
California
-$3.99M
4
Bank of America
Bank of America
North Carolina
-$1.62M
5
ABG
Ally Bridge Group
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWA
76
EverSource Wealth Advisors
Alabama
$11 +$15 +9 New
Janus Henderson Group
77
Janus Henderson Group
United Kingdom
– -$5.72M -3,184,200 Closed
SB
78
Samsara BioCapital
California
– -$4.7M -2,609,114 Closed
ABG
79
Ally Bridge Group
New York
– -$1.37M -760,225 Closed
PHP
80
Parkman Healthcare Partners
Connecticut
– -$523K -290,491 Closed
SBH
81
Segall Bryant & Hamill
Illinois
– -$223K -123,956 Closed
SCM
82
Superstring Capital Management
New York
– -$177K -98,160 Closed
Walleye Capital
83
Walleye Capital
New York
– -$112K -62,039 Closed
B
84
Bailard
California
– -$102K -56,800 Closed
Squarepoint
85
Squarepoint
New York
– -$55.5K -30,845 Closed
American Century Companies
86
American Century Companies
Missouri
– -$24.6K -13,684 Closed
VF
87
Virtu Financial
New York
– -$21K -11,733 Closed
ProShare Advisors
88
ProShare Advisors
Maryland
– -$20.6K -11,469 Closed
RS
89
R Squared
Hong Kong
– -$2.39K -1,330 Closed
Nisa Investment Advisors
90
Nisa Investment Advisors
Missouri
– -$409 -227 Closed
1 2 3
4

CLYM Hedge Fund Activity: Q1 2025 in Review

76 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q1 2025, worth a combined $63.4M — down 37% from $100M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CLYM and 10 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 23 added.

The largest buyer was Citigroup, adding an estimated $2.96M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $5.72M sold.

  • 76 institutional investors held Climb Bio (CLYM) as of Q1 2025, down from 80 in Q4 2024.
  • Funds reported $63.4M of Climb Bio stock for Q1 2025, down 37% quarter-over-quarter.
  • 10 funds opened new Climb Bio positions in Q1 2025 and 14 closed out, a net change of -4 holders.
  • The largest Climb Bio buyer in Q1 2025 was Citigroup, an estimated $2.96M added.
  • The largest Climb Bio seller in Q1 2025 was Janus Henderson Group, an estimated $5.72M sold.

Based on aggregated 13F filings for Q1 2025.